physician photo

Adetunji T. Toriola, MD, PhD

Assistant Professor of Surgery


Learn more about Dr. Toriola's research

Medical School

MD, Obafemi Awolowo University, Ile-Ife, Nigeria, 1998
DA (Diploma in Anesthesia), West African College of Surgeons, 2004

Graduate School

MPH (Master of Science in Public Health), University of Kuopio, Kuopio, Finland, 2007
PhD (Epidemiology), University of Tampere, Tampere, Finland, 2011

Post Doctoral Education

Postdoctoral Fellowship, German Cancer Research Center (DKFZ), Heidelberg, Germany, 2011-2012

Honors and Awards

2004: Travel Fellowship Award, Obstetrics Anesthetics Association of UK
2007: Scholarship, European Union Cancer Control using Population based Registries and Biobank (EU-CCPRB) and University of Tampere, Finland
2008: Global Health Travel Award, Bill and Melinda Gates Foundation and Keystone
2010: Scholarship, European Association for Cancer Research
2010: Poster Prize Award, European Society for Biomedical Research on Alcoholism Symposium, Heidelberg, Germany
2010: Travel Fellowship Award, European Association for Cancer Research.
2011: Post-doctoral Fellowship Award, German Cancer Research Center (DKFZ), Heidelberg, Germany
2011: Travel Award, GlaxoSmithKline (GSK)
2013: Integrative Molecular Epidemiology Workshop, American Association for Cancer Research (AACR), Selected Participant
2013: Faculty Diversity Scholar, Washington University School of Medicine
2015: Career Catalyst Research Grant (Basic/Translational), Susan G. Komen

Research Interests

Dr. Toriola’s research interest focuses on the use of biomarkers to investigate the associations of energetics, hormones and inflammation with cancer risk and survival. He is especially interested in the interplay between inflammation and insulin resistance in cancer risk and mortality and the translational importance of such relationship. He has taken leading roles in studies conducted within large cohorts such as the Women’s Health Initiative Observational Study, Finnish Maternity Cohort, Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial and Kuopio Ischemic Heart Disease Risk Factor Study.

Contact Information

660 S. Euclid Avenue
Campus Box 8100
St. Louis, MO 63110
(314) 268-2668
a.toriola@wustl.edu

Selected Publications

Alimujiang A, Imm K, Appleton C, Colditz GA, Berkey CS, Toriola AT. Adiposity at age 10 and mammographic density among premenopausal women. Cancer Prev Res (Phila). 2018 Mar 2. pii: canprevres.0309.2017. doi: 10.1158/1940-6207.CAPR-17-0309. PMID: 29500187.

Toriola AT, Dang HA, Hagermann IS, Appleton CM, Colditz GA, Luo J, Maher CA. Increased breast tissue receptor activator of nuclear factor- kB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women. Oncotarget. 2017 May 17;8(43):73787-73792. doi: 10.18632/oncotarget.17909. eCollection 2017 Sep 26. PMID: 29088745.

Yang L, Toriola AT. Inflammation Modifies the Association of Obesity with Circulating 25-Hydroxyvitamin D Levels in Cancer Survivors. Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S58-S65. doi: 10.1002/oby.22011. PMID: 29086515. 

Toriola AT, Ziegler M, Li Y, Pollak M, Stolzenberg-Solomon R. Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival. Ann Surg Oncol. 2017 Oct;24(11):3212-3219. doi: 10.1245/s10434-017-5988-y. PMID: 28681154.

Rosner B, Eliassen HA, Toriola AT, Chen WY, Hankinson SE, Willet WC, Berkey CS, Colditz GA. Weight and weight changes in early adulthood and later breast cancer risk. Int. J Cancer. 2017 140(9):2003-2014. PMID: 28801763. 

Fortner RT, Schock H, Kaaks R, Lehtinen M, Pukkala E, Lakso HÅ, Tanner M, Kallio R, Joensuu H, Korpela J, Toriola AT, Hallmans G, Grankvist K, Zeleniuch-Jacquotte A, Toniolo P, Lundin E, Surcel HM. Human chorionic gonadotropin does not correlate with risk for maternal breast cancer: results from the Finnish maternity cohort. Cancer Res. 2017;77(1):134-141. PMID: 27784743.

Nywening TM, Wang-Gillam A, Sanford DE, Belt BA, Panni RZ, Cusworth BM, Toriola AT, Nieman RK, Worley LA, Yano M, Fowler KJ, Lockhart AC, Suresh R, Tan BR, Lim KH, Fields RC, Strasberg SM, Hawkins WG, DeNardo DG, Goedegebuure SP, Linehan D. Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncol. 2016;17(5):651-62. doi: 10.1016/S1470-2045(16)00078-4. PMID: 27055731.

Morrison L, Laukkanen JA, Ronkainen K, Kurl S, Kauhanen J, Toriola AT. Inflammatory biomarker score and cancer: A population-based prospective cohort study. BMC Cancer 2016: 10;16:80. doi: 10.1186/s12885-016-2115-6. PMID: 26860264.

Toriola AT, Liu J, Ganz PA, Colditz GA, Yang L, Izadi S, Naughton MJ, Schwartz AL, Wolin KY. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors. Breast Cancer Res Treat. 2015;152(3):637-43. PMID: 26175059. PMCID: PMC4521978.

Toriola AT, Nguyen N, Scheitler-Ring K, Colditz G. Circulating 25-hydroxyvitamin D (25-OHD) levels and prognosis among cancer patients: a systematic review. Cancer Epidemiol Biomark Prev. 2014:23(6); 917-933. PMID: 24692501. 

Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G. Diabetes and pancreatic cancer survival: a prospective cohort-based study. Br J Cancer 2014:111(1): 181-5. 

Toriola AT, Laukannen JA, Kurl S, Nyyssonen K, Ronkainen K, Kauhanen J. Pre-diagnostic circulating markers of inflammation and risk of prostate cancer. International Journal of Cancer 2013:133 (12); 2961-7.

Toriola AT, Cheng T-YD, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SAA, Gunter MJ, Caudill MA, Ulrich CM. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 2013:132(11):2648-59. PMID: 23161620.

Toriola AT, Grankvist K, Agborsangaya C, Lukanova A, Lehtinen M, Surcel HM. Changes in C-reactive protein concentrations and the risk of ovarian cancer: a longitudinal study. Ann Oncol 2011; 22(8): 1916-1921. PMID: 21292643.

Toriola AT, Lundin E, Lehtinen M, Grankvist K, Pukkala E, Chen T, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Surcel HM, Lukanova A. Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomark Prev 2011;20(8):1798-1801. PMID: 21680537 PMCID: PMC3153607.


Editorial Positions

Guest Associate Editor, Frontiers in Oncology, Inflammation and Cancer Risk: An Evaluation of Biomarker Profiles

Reviewer for: 
  • Annals of Epidemiology
  • Annals of Oncology
  • British Journal of Cancer
  • European Journal of Cancer Prevention
  • Canadian Medical Association Journal
  • Cancer Causes and Control
  • Cancer Epidemiology Biomarkers and Prevention
  • Carcinogenesis
  • Diabetic Medicine
  • Lung Cancer
  • International Journal of Cancer
  • Tumor Biology